GW679769
GW679769 is a pharmaceutical drug with 13 clinical trials. Historical success rate of 92.3%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
10
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
92.3%
12 of 13 finished
7.7%
1 ended early
0
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
Post-Operative Nausea And Vomiting Study In Female Patients
Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
Clinical Trials (13)
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia
Post-Operative Nausea And Vomiting Study In Female Patients
Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
Study Of GW679769 In Major Depressive Disorder
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
GW679769 In Fibromyalgia
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia
Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy
fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13